₹14.38
■ +0 +0.00%
18 Jul 2026
BSE Listed
GSM 2Adline Chem Lab Limited (524604)
Volume: 0Avg Vol 1W: 100Avg Vol 1M: 77752W Range:₹7.6₹18.1
Key Ratios
Checked 5h agoMarket Cap₹8 Cr
Current Price₹14.38
Previous Close₹14.38
High / Low (52w)₹18.1 / ₹7.6
Volume0
Avg Vol (1W)100
Avg Vol (1M)777
Stock P/E—
Book Value₹-3.03
Dividend Yield0%
ROE15.84%
ROA-385.71%
Revenue (TTM)—
Revenue Growth—
Profit Margin0%
Total Debt—
Shares Outstanding1 Cr
Face Value—
EPS (TTM)₹0
P/B0
Debt / Equity0
50 DMA₹11.87
200 DMA₹15.54
Day change+0.00%
SurveillanceGSM 2 (as of 2026-07-17)
Price Chart
₹14.38▼ 8.35% · 1Y
2025-07-172026-07-17
20-day avg volume: 545 shares
Pros
- Healthy return on equity of 15.8%.
- Company is almost debt-free.
- Revenue grew 248800% YoY.
Cons
- Company is loss-making at the latest annual result.
- Negative book value per share.
Quarterly Results
| Metric | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| EBITDA | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Net Profit | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹8 Cr | ₹6 Cr | ₹7 Cr | ₹6 Cr | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr |
| EBITDA | ₹0 Cr | ₹0 Cr | ₹-4 Cr | ₹-1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Net Profit | ₹0 Cr | ₹0 Cr | ₹-4 Cr | ₹-1 Cr | ₹1 Cr | ₹-4 Cr | ₹0 Cr | ₹0 Cr |
| EPS | 0 | 0.05 | -6.45 | -2.19 | 1.23 | -7.24 | -0.46 | -0.21 |
Balance Sheet
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹23 Cr | ₹22 Cr | ₹8 Cr | ₹6 Cr | ₹5 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Total Liabilities | ₹16 Cr | ₹15 Cr | ₹4 Cr | ₹4 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹2 Cr |
| Equity | ₹7 Cr | ₹7 Cr | ₹3 Cr | ₹2 Cr | ₹3 Cr | ₹-2 Cr | ₹-1 Cr | ₹-1 Cr |
| Total Debt | — | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Operating | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Investing | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Financing | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Free Cash Flow | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
Shareholding
Promoter 25.85% Institutions 0% Public 74.15%
Efficiency & Working Capital
ROCE-495.8%
Interest Coverage-0.2
Dividend Payout—
Debtor Days—
Inventory Days—
Payable Days—
Cash Conversion Cycle—
Working Capital Days—
Shareholding Details
As of 2026-03-31
Promoter25.9%
FII0%
DII0%
Institutions0%
Public74.1%
Promoter Pledge0%
No. of Shareholders18,446
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 28.2% | 28.2% | 28.2% | 29.6% | 29.6% | 29.6% | 29.6% | 29.6% | 29.6% | 29.6% | 25.9% | 25.9% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 71.8% | 71.8% | 71.8% | 70.4% | 70.4% | 70.4% | 70.4% | 70.4% | 70.4% | 70.4% | 74.1% | 74.1% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 18,661 | 18,638 | 18,628 | 18,595 | 18,583 | 18,536 | 18,509 | 18,514 | 18,481 | 18,488 | 18,468 | 18,446 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Hemant Amrish Parikh | Shareholding of Promoter and Promoter Group | 25.9% | 15,12,440 |
| Sonal R Bambhania | Public Shareholding | 1.1% | 66,600 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Hemant Amrish Parikh | 0 | 0% | 2026-03-31 |
| Sonal R Bambhania | 0 | 0% | 2026-03-31 |
| Hemant Amrish Parikh | 0 | 0% | 2025-12-31 |
| Sonal R Bambhania | 0 | 0% | 2025-12-31 |
| Hemant Amrish Parikh | 0 | 0% | 2025-09-30 |
| Balkrishna B Patel | 0 | 0% | 2025-09-30 |
| Jagrutiben J Laskari | 0 | 0% | 2025-09-30 |
| Gaurav B Patel | 0 | 0% | 2025-09-30 |
| Priyanka A Patel | 0 | 0% | 2025-09-30 |
| Paulomi Zabal Laskari | 0 | 0% | 2025-09-30 |
| Paulomy Lashkari | 0 | 0% | 2025-09-30 |
| Dineshchandra Bhikhabhai Patel | 0 | 0% | 2025-09-30 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Dhawal Akhilesh Deopura | Independent Director | 2025 |
| Shivani Pathak | Independent Director | 2025 |
| Krish Patel | Independent Director | 2025 |
| Him Vyas | Independent Director | 2025 |
| Vrushank Balkrushna Patel | Chairman & Executive Director | 2025 |
| Nilay Jitendrabhai Vaghasiya | Executive Director | 2025 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Pharmaceuticals and Nutraceuticals | ₹1 Cr | 100% |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹10 | 6 | 6 | 6 |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 0 | 0 | 0 | 0 | 1 | 1 |
| 2025 | 0 | 0 | 0 | 0 | 1 | 1 |
| 2025 | 0 | 0 | 0 | 0 | 1 | 1 |
Substantial Acquisitions (SAST)
6 disclosure(s)
Off Market01/02/2024 · 14,32,040
Off Market01/02/2024 · 14,32,040
Off Market31/01/2024 · 14,32,040
Off Market31/01/2024 · 14,32,040
Off Market31/01/2024 · 14,32,040
Off Market31/01/2024 · 14,32,040
Company Information
Incorporated1988
ChairmanVrushank Balkrushna Patel
AuditorDeepak Soni & Associates/Jain Kedia & Sharma
Investor Email[email protected]
📍 A-514 Steller Opp Arista Bldg, Sindhu bhavan Road Bodakdev, Ahmedabad, Gujarat, 380054
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search